zindaclin clindamycin (as clindamycin phosphate) 1% topical gel tube
medis pharma pty ltd - clindamycin phosphate, quantity: 1.188 % w/w - gel - excipient ingredients: propylene glycol; sodium hydroxide; purified water; hyetellose; ethanol; zinc acetate - zindaclin is indicated for the treatment of acne vulgaris, particularly forms in which comedones, papules and pustules predominate.
zindaclin 1 % gel
taro international ltd, israel - clindamycin phosphate - gel - clindamycin phosphate 1 %w/w - clindamycin - clindamycin - zindaclin is indicated for the treatment of acne vulgaris.
zydaclin- clindamycin hydrochloride tablet
vetone - clindamycin hydrochloride (unii: t20oq1yn1w) (clindamycin - unii:3u02el437c) - zydaclin™ tablets (clindamycin hydrochloride tablets) (for use in dogs only) are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below: dogs: skin infections (wounds and abscesses) due to: coagulase positive staphylococci (staphylococcus aureus or staphylococcus intermedius ). deep wounds and abscesses due to bateroides fragilis , prevotella melaninogenicus , fusobacterium necrophorum and clostridium perfringens . dental infections due to staphyloccus aureus, bacteroides fragilis, prevotella melaninogenicus, fusobacterium necrophorum and clostridium perfringens . osteomyelitis due to staphylococcus aureus, bacteroides fragilis, prevotella melaninogenicus, fusobacterium necrophorum and clostridium perfringens . zydaclin tablets are contraindicated in animals with a history of hypersensitivity to preparations containing clindamycin or lincomycin. because of potential adverse gastrointestinal effects, do not administer to rabbits, hamsters, guinea pigs, horses, chinchillas or ruminating animals.
zydaclin- clindamycin solution/ drops
mwi - clindamycin hydrochloride (unii: t20oq1yn1w) (clindamycin - unii:3u02el437c) - clindamycin 25 g in 1 ml - indications zydaclin™ oral drops (for use in dogs and cats) are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below: dogs: skin infections (wounds and abscesses) due to coagulase positive staphylococci (staphylococcus aureus or staphylococcus intermedius). deep wounds and abscesses due to bacteroides fragilis, prevotella melaninogenicus, fusobacterium necrophorum and clostridium perfringens. dental infections due to staphylococcus aureus, bacteroides fragilis, prevotella melaninogenicus, fusobacterium necrophorum and clostridium perfringens. osteomyelitis due to staphylococcus aureus, bacteroides fragilis, prevotella melaninogenicus, fusobacterium necrophorum and clostridium perfringens. cats: skin infections (wounds and abscesses) due to staphylococcus aureus, staphylococcus intermedius, streptococcus spp . deep wounds and abscesses due to clostridium perfringens and bacteroides fragilis . dental infections
zindaclin
actavis pty ltd - clindamycin phosphate -
zindaclin 1% gel
canute pharma ltd - clindamycin phosphate - cutaneous gel - 10mg/1gram
zindaclin 1% gel
lexon (uk) ltd - clindamycin phosphate - cutaneous gel - 10mg/1gram
zindaclin 1% gel
orient europharma (m) sdn bhd - clindamycin phosphate -
zindaclin 1% gel
kci europe holding b.v. - clindamycin phosphate - gel - 1 percent weight/weight - antiinfectives for treatment of acne; clindamycin
zindaclin 1% gel
canute pharma (ireland) limited - clindamycin phosphate - gel - 1 percent weight/weight - antiinfectives for treatment of acne; clindamycin